Reported covered position: Senator Baldwin
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
National Security Diversity and Inclusion Workforce Act of 2021
Client: AMERICAN LIVER FOUNDATION · Firm: PYXIS PARTNERS, LLC
HR. 1225 Living Donor Protection Act of 2021, NAFLD, FY25 AHRQ Appropriations
Technical Correction to the Shoshone-Paiute Tribes of the Duck Valley Reservation Water Rights Settlement Act of 2023
Client: ASSOCIATION FOR COMMUNITY AFFILIATED PLAN · Firm: PYXIS PARTNERS, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2026 · first_quarter · Q1
Right2 To FDA Approved Products legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · fourth_quarter · Q4
Source: Senate LDA
IDEAL Act and HR 1738 PATIENT act
Promoting Transparency and Healthy Competition in Medicare Act
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: PYXIS PARTNERS, LLC
H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act
Promoting Transparency and Healthy Competition in Medicare Act
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: PYXIS PARTNERS, LLC
H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act
National Security Diversity and Inclusion Workforce Act of 2021
Client: AMERICAN LIVER FOUNDATION · Firm: PYXIS PARTNERS, LLC
HR. 1225 Living Donor Protection Act of 2021
National Security Diversity and Inclusion Workforce Act of 2021
Client: AMERICAN LIVER FOUNDATION · Firm: PYXIS PARTNERS, LLC
HR. 1225 Living Donor Protection Act of 2021
Stabilize Medicaid and CHIP Coverage Act
Client: ASSOCIATION FOR COMMUNITY AFFILIATED PLAN · Firm: PYXIS PARTNERS, LLC
Medicaid & CHIP Policies H.R. 1738
Right To FDA Approved Products legislation
Filing targets: SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · third_quarter · Q3
Right To FDA Approved Products legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · second_quarter · 2A
Right To FDA Approved Products legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2025 · third_quarter · Q3
Medicaid/ACA Defense
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2025 · third_quarter · Q3
Medicaid Defense/ ACA Defense
Filing targets: SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2025 · first_quarter · 1A
MA for Tomorrow
Filing targets: HOUSE OF REPRESENTATIVES
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · second_quarter · Q2
Right To FDA Approved Products legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · first_quarter · 1A
Comstock Act, TBD on a bill focused on protecting access to FDA approved drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2025 · second_quarter · 2A
Medicaid Defense/ ACA Defense
Filing targets: SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2025 · second_quarter · Q2
Medicaid Defense/ ACA Defense
Filing targets: SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · second_quarter · Q2
Right To FDA Approved Products legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2025 · second_quarter · 2A
Medicaid/ACA defense
Medicaid/ACA Defense
Filing targets: HOUSE OF REPRESENTATIVES
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · second_quarter · Q2
Medicaid/ACA defense in the reconciliation bill
Filing targets: SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · first_quarter · 1A
Comstock Act, TBD on a bill focused on protecting access to FDA approved drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · second_quarter · Q2
Medicaid/ACA defense in the reconciliation bill
Filing targets: SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2025 · second_quarter · Q2
Medicaid/ACA defense
Medicaid/ACA Defense
Filing targets: HOUSE OF REPRESENTATIVES
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · first_quarter · Q1
Comstock Act, TBD on a bill focused on protecting access to FDA approved drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2025 · first_quarter · Q1
Comstock Act, TBD on a bill focused on protecting access to FDA approved drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2025 · first_quarter · Q1
MA for Tomorrow
Filing targets: HOUSE OF REPRESENTATIVES
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2025 · first_quarter · Q1
Medicaid Defense
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN LIVER FOUNDATION via PYXIS PARTNERS, LLC
2024 · fourth_quarter · 4T
FY25 AHRQ Appropriations
Filing targets: SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2024 · fourth_quarter · Q4
Comstock act and implications for Abortion Care Nationwide, Right To Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2024 · fourth_quarter · Q4
Continuous Eligibility and SCMA Letter, Medicaid rates
Filing targets: HOUSE OF REPRESENTATIVES
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2024 · fourth_quarter · Q4
Comstock act and implications for Abortion Care Nationwide, Right To Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN LIVER FOUNDATION via PYXIS PARTNERS, LLC
2024 · fourth_quarter · Q4
FY25 AHRQ Appropriations
Filing targets: SENATE
AMERICAN LIVER FOUNDATION via PYXIS PARTNERS, LLC
2024 · third_quarter · Q3
HR. 1225 Living Donor Protection Act of 2021, NAFLD, FY25 AHRQ Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2024 · third_quarter · Q3
Comstock act and implications for Abortion Care Nationwide, Right To Legislation
Filing targets: HOUSE OF REPRESENTATIVES
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2024 · third_quarter · Q3
APTC letter in House and Senate
Filing targets: HOUSE OF REPRESENTATIVES
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2024 · third_quarter · Q3
Continuous Eligibility and SCMA Letter
Filing targets: HOUSE OF REPRESENTATIVES
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2024 · second_quarter · Q2
Comstock act and implications for Abortion Care Nationwide
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2024 · first_quarter · Q1
SMCA
AMERICAN LIVER FOUNDATION via PYXIS PARTNERS, LLC
2023 · third_quarter · 3A
HR. 1225 Living Donor Protection Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2023 · second_quarter · 2A
H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act
Filing targets: HOUSE OF REPRESENTATIVES
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2023 · third_quarter · 3A
PATIENT Act, SMCA and IDEAL Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2023 · fourth_quarter · Q4
SMCA
Filing targets: SENATE
AMERICAN LIVER FOUNDATION via PYXIS PARTNERS, LLC
2023 · third_quarter · Q3
HR. 1225 Living Donor Protection Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2023 · third_quarter · Q3
Part C and Part D Ownership transparency provision of PATIENT Act
Filing targets: HOUSE OF REPRESENTATIVES
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2023 · third_quarter · Q3
IDEAL Act and HR 1738 PATIENT act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2023 · second_quarter · Q2
H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act
Filing targets: HOUSE OF REPRESENTATIVES
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2022 · fourth_quarter · Q4
Medicaid & CHIP Policies H.R. 1738
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2022 · third_quarter · Q3
Ideal ACT Proposal - Medicaid Priorities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK STEM CELL FOUNDATION, INC. via PYXIS PARTNERS, LLC
2022 · second_quarter · Q2
Stem Cell Research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK STEM CELL FOUNDATION, INC. via PYXIS PARTNERS, LLC
2022 · second_quarter · RR
Appropriations for Stem Cell Research
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2022 · second_quarter · Q2
APTC's, Drug Pricing, Medicare Advantage
Filing targets: HOUSE OF REPRESENTATIVES
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2021 · third_quarter · RA
Comstock
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2021 · fourth_quarter · Q4
H. Resolution 589
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAEBURN INC. via PYXIS PARTNERS, LLC
2021 · fourth_quarter · Q4
DEA IFR Issues - 14-day rule and Fairness in Orphan Drug Exclusivity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2021 · fourth_quarter · Q4
The Stabilize Medicaid and CHIP Act Medicaid Adult Quality Measures Short Term Limited Duration Insurance Plans Enhancement of ACA Premium Tax Credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2021 · third_quarter · Q3
H. Resolution 589
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE HOPEWELL FOUNDATION FKA HOPEWELL FUND via PYXIS PARTNERS, LLC
2021 · third_quarter · RR
H. Resolution 589
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2021 · third_quarter · Q3
The Stabilize Medicaid and CHIP Act Medicaid Adult Quality Measures Short Term Limited Duration Insurance Plans Enhancement of ACA Premium Tax Credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAEBURN INC. via PYXIS PARTNERS, LLC
2021 · third_quarter · Q3
DEA IFR Issues - 14-day rule and Fairness in Orphan Drug Exclusivity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2021 · second_quarter · Q2
Access to telehealth services for patients
BRAEBURN INC. via PYXIS PARTNERS, LLC
2021 · second_quarter · Q2
DEA IFR Issues - 14-day rule and Fairness in Orphan Drug Exclusivity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2021 · second_quarter · Q2
The Stabilize Medicaid and CHIP Act Medicaid Adult Quality Measures Short Term Limited Duration Insurance Plans Enhancement of ACA Premium Tax Credits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAEBURN INC. via PYXIS PARTNERS, LLC
2021 · first_quarter · 1A
DEA IFR Issues - 14-day rule and Fairness in Orphan Drug Exclusivity Act
Filing targets: SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2021 · first_quarter · 1A
The Stabilize Medicaid and CHIP Act Medicaid Adult Quality Measures Short Term Limited Duration Insurance Plans Enhancement of ACA Premium Tax Credits
Filing targets: HOUSE OF REPRESENTATIVES
ASSOCIATION FOR COMMUNITY AFFILIATED PLAN via PYXIS PARTNERS, LLC
2021 · first_quarter · RR
Medicaid Stabilization Act, CE Medicaid Bill, and STDLI legislation
ALLIANCE OF COMMUNITY HEALTH PLANS via PYXIS PARTNERS, LLC
2020 · third_quarter · RR
cost and reimbursement of prescription drugs, the regulation of biomedical products
BRAEBURN INC. via PYXIS PARTNERS, LLC
2020 · third_quarter · RR
DEA IFR Issues, 14-day rule and Fairness in Orphan Drug Exclusivity act